Mycoplasma pneumoniaeand Its Role as a Human Pathogen

10.1128/JCM.36.2.548-551.1998

Abele-Horn, M., W. Franck, U. Busch, H. Nitschko, R. Roos, and J. Heesemann. 1998. Transverse myelitis associated with Mycoplasma pneumoniae infection. Clin. Infect. Dis.26:909-912.

Abramovitz, P., P. Schvartzman, D. Harel, I. Lis, and Y. Naot. 1987. Direct invasion of the central nervous system by Mycoplasma pneumoniae: a report of two cases. J. Infect. Dis.155:482-487.

Agustin, E. T., V. Gill, and B. A. Cunha. 1994. Mycoplasma pneumoniae meningoencephalitis complicated by diplopia. Heart Lung23:436-437.

Alexander, E. R., H. M. Foy, G. E. Kenny, R. A. Kronmal, R. McMahan, E. R. Clarke, W. A. MacColl, and J. T. Grayston. 1966. Pneumonia due to Mycoplasma pneumoniae. Its incidence in the membership of a co-operative medical group. N. Engl. J. Med.275:131-136.

10.1128/jcm.34.5.1180-1183.1996

Ali, N. J., M. Sillis, B. E. Andrews, P. F. Jenkins, and B. D. Harrison. 1986. The clinical spectrum and diagnosis of Mycoplasma pneumoniae infection. Q. J. Med.58:241-251.

10.1172/JCI111279

Al-Mateen, M., M. Gibbs, R. Dietrich, W. G. Mitchell, and J. H. Menkes. 1988. Encephalititis lethargica-like illness in a girl with mycoplasma infection. Neurology38:1155-1158.

Andrews, P. A., C. M. Lloyd, M. C. Webb, and S. H. Sacks. 1994. Acute interstitial nephritis associated with Mycoplasma pneumoniae infection. Nephrol. Dial. Transplant.9:564-566.

10.1097/00005176-199511000-00015

Arnold, S. E. 1987. Psychosis and Mycoplasma pneumoniae. Hillside J. Clin. Psychiatr.9:231-235.

Aubert, G., B. Pozzetto, O. G. Gaudin, J. Hafid, A. D. Mbida, and A. Ros. 1992. Evaluation of five commercial tests: complement fixation, microparticle agglutination, indirect immunofluorescence, enzyme-linked immunosorbent assay and latex agglutination, in comparison to immunoblotting for Mycoplasma pneumoniae serology. Ann. Biol. Clin. (Paris)50:593-597.

Aubert, G., B. Pozzetto, J. Hafid, and O. G. Gaudin. 1992. Immunoblotting patterns with Mycoplasma pneumoniae of serum specimens from infected and non-infected subjects. J. Med. Microbiol.36:341-346.

Balish M. F. and D. C. Krause. 2002. Cytadherence and the cytoskeleton p. 491-518. In S. Razin and R. Herrman (ed.) Molecular biology and pathogenicity of mycoplasmas. Kluwer Academic/Plenum Publishers New York N.Y.

Barile M. F. 1979. Mycoplasma-tissue cell interactions p. 425-474. In J. G. Tully and R. F. Whitcomb (ed.) The mycoplasmas II. Human and animal mycoplasmas vol. 2. Academic Press New York N.Y.

10.1128/iai.56.9.2443-2449.1988

10.1128/iai.56.9.2450-2457.1988

Barile, M. F., M. W. Grabowski, K. Kapatais-Zoumbois, B. Brown, P. C. Hu, and D. K. Chandler. 1994. Protection of immunized and previously infected chimpanzees challenged with Mycoplasma pneumoniae. Vaccine12:707-714.

Barile, M. F., M. W. Grabowski, P. J. Snoy, and D. K. Chandler. 1987. Superiority of the chimpanzee animal model to study the pathogenicity of known Mycoplasma pneumoniae and reputed mycoplasma pathogens. Isr. J. Med. Sci.23:556-560.

Barile, M. F., K. Kapatais-Zoumbos, P. Snoy, M. W. Grabowski, M. Sneller, L. Miller, and D. K. Chandler. 1994. Experimentally induced septic arthritis in chimpanzees infected with Mycoplasma hominis. Mycoplasma pneumoniae, and Ureaplasma urealyticum. Clin. Infect. Dis.18:694-703.

10.1136/jcp.43.2.163

Bar Meir, E., H. Amital, Y. Levy, A. Kneller, Y. Bar-Dayan, and Y. Shoenfeld. 2000. Mycoplasma-pneumoniae-induced thrombotic thrombocytopenic purpura. Acta Haematol.103:112-115.

10.1016/0002-9343(72)90073-3

10.1086/313954

Baseman J. B. 1993. The cytadhesins of Mycoplasma pneumoniae and M. genitalium p. 243-259. In S. Rottem and I. Kahane (ed.) Subcellular biochemistry. Plenum Press New York N.Y.

10.1128/iai.38.1.389-391.1982

10.1006/mpat.1995.0050

Baseman, J. B., J. Morrison-Plummer, D. Drouillard, B. Puleo-Scheppke, V. V. Tryon, and S. C. Holt. 1987. Identification of a 32-kilodalton protein of Mycoplasma pneumoniae associated with hemadsorption. Isr. J. Med. Sci.23:474-479.

10.1164/ajrccm/154.4_Pt_2.S137

10.3201/eid0301.970103

Bebear, C., M. Dupon, H. Renaudin, and B. de Barbeyrac. 1993. Potential improvements in therapeutic options for mycoplasmal respiratory infections. Clin. Infect. Dis.17(Suppl. 1):S202-S207.

Bebear C. and J. A. Robertson. 1996. Determination of minimal inhibitory concentration p. 189-197. In J. G. Tully and S. Razin (ed.) Molecular and diagnostic procedures in mycoplasmology vol. II. Academic Press New York N.Y.

Bebear C. M. and C. Bebear. 2002. Antimycoplasmal agents p. 545-566. In S. Razin and R. Herrmann (ed.) Molecular biology and pathogenicity of mycoplasmas. Kluwer Academic/Plenum Publishers New York N.Y.

10.1128/AAC.42.3.703

Bebear, C. M., H. Renaudin, T. Schaeverbeke, F. LeBlanc, and C. Bebear. 2000. Comparative activities of telithromycin (HMR 3647), levofloxacin and other antimicrobial agents against human mycoplasmas. Antimicrob. Agents Chemother.47:1980-1982.

10.1128/AAC.43.4.954

Becton, D. L., H. S. Friedman, J. Kurtzberg, S. Chaffee, J. M. Falletta, and T. R. Kinney. 1986. Severe Mycoplasma pneumonia in three sisters with sickle cell disease. Pediatr. Hematol. Oncol.3:259-265.

Behan, P. O., R. G. Feldman, J. M. Segerra, and I. T. Draper. 1986. Neurological aspects of mycoplasmal infection. Acta Neurol. Scand.74:314-322.

Benisch, B. M., A. Fayemi, and M. A. Gerber. 1972. Mycoplasmal pneumonia in a patient with rheumatic heart disease. Am. J. Clin. Pathol.58:343-348.

Berger, R. P., and R. M. Wadowksy. 2000. Rhabdomyolysis associated with infection by Mycoplasma pneumoniae: a case report. Pediatrics105:433-436.

Berkovich, S., S. J. Millian, and R. D. Snyder. 1970. The association of viral and mycoplasma infections with reurrence of wheezing in the asthmatic child. Ann. Allergy28:43-49.

10.1128/jcm.27.11.2492-2496.1989

Beskind, D. L., and S. M. Keim. 1994. Choreoathetotic movement disorder in a boy with Mycoplasma pneumoniae encephalitis. Ann. Emerg. Med.23:1375-1378.

Biberfield, G., T. Johnsson, and J. Johnsson. 1965. Studies on Mycoplasma pneumoniae infection in Sweden. Acta Pathol. Microbiol. Scand.63:469-475.

Blackmore, T. K., M. Reznikov, and D. L. Gordon. 1995. Clinical utility of the polymerase chain reaction to diagnose Mycoplasma pneumoniae infection. Pathology27:177-181.

10.1097/00006454-199506000-00002

Brouard, J., F. Freymuth, F. Toutain, N. Bach, A. Vabret, S. Gouarin, J. Petitjean, and J. F. Duhamel. 2002. Role of viral infections and Chlamydia pneumoniae and Mycoplasma pneumoniae infections in asthma in infants and young children. Epidemiologic study of 118 children. Arch. Pediatr.9(Suppl. 3):365s-371s.

Brouard, J., J. Petitjean, F. Freymuth, and J. F. Duhamel. 1989. Mycoplasma pneumoniae respiratory infection in a child presenting with positive HIV 1 serology. Arch. Fr. Pediatr.46:155-156.

Brunner, H. 1981. Protective efficacy of Mycoplasma pneumoniae polysaccharides. Isr. J. Med. Sci.17:678-681.

Brunner, H., H. Greenberg, W. D. James, R. L. Horswood, and R. M. Chankock. 1973. Decreased virulence and protective effect of genetically stable temperature sensitive mutants of Mycoplasma pneumoniae. Ann. N. Y. Acad. Sci.225:436-452.

Brunner, H., and B. Prescott. 1982. Effect of Mycoplasma pnuemoniae polysaccharides and glycolipids on prophylaxis of experimental disease. Semin. Infect. Dis.4:190-197.

10.1128/jcm.30.12.3280-3283.1992

Buscho, R. O., D. Saxtan, P. S. Shultz, E. Finch, and M. A. Mufson. 1978. Infections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitis. J. Infect. Dis.137:377-383.

Reference deleted.

Campbell, T. A., P. S. Strong, and G. S. Grier. 1943. Primary atypical pneumonia: two hundred cases at Ft. Eustin, Virginia. JAMA122:723-729.

Carbon, C., S. Moola, I. Velancsics, B. Leroy, M. Rangaraju, and P. Decosta. 2003. Telithromycin 800 mg once daily for seven to ten days is an effective and well-tolerated treatment for community-acquired pneumonia. Clin. Microbiol. Infect.9:691-703.

Carpenter, T. C. 2002. Corticosteroids in the treatment of etriatal encephalitis complicating Mycoplasma pneumoniae pneumonia: possible benefit of intravenous immunoglobulin. Pediatr. Infect. Dis. J.20:534-545.

Carstensen, H., and K. O. Nilsson. 1987. Neurological complications associated with Mycoplasma pneumoniae infection in children. Neuropediatrics18:57-58.

10.3201/eid0403.980339

Cassell G. H. W. A. Clyde Jr. and J. K. Davis. 1985. Mycoplasma respiratory infections p. 65-106. In S. Razin and M. F. Barile (ed.) The mycoplasmas vol. 4. Academic Press New York N.Y.

10.1056/NEJM198101083040204

Cassell, G. H., J. Drnec, K. B. Waites, M. S. Pate, L. B. Duffy, H. L. Watson, and J. C. McIntosh. 1991. Efficacy of clarithromycin against Mycoplasma pneumoniae. J. Antimicrob. Chemother.27(Suppl. A):47-59.

Cassell G. H. G. Gambill and L. B. Duffy. 1996. ELISA in respiratory infections of humans p. 123-136. In J. G. Tully and S. Razin (ed.) Molecular and diagnostic procedures in diagnostic mycoplasmology. Academic Press New York N.Y.

Chan, E. D., and C. H. Welsh. 1995. Fulminant Mycoplasma pneumoniae pneumonia. West. J. Med.162:133-142.

10.1056/NEJM196003312621303

Chanock, R. M., L. Dienes, M. D. Eaton, D. G. Edward, E. A. Freundt, L. Hayflick, J. F. P. Hers, K. E. Jensen, C. Liu, B. P. Marmion, M. A. Mufson, P. F. Smith, N. L. Somerson, and D. Taylor-Robinson. 1963. Mycoplasma pneumoniae: proposed nomenclature for atypical pneumonia organism (Eaton agent). Science140:662.

10.1073/pnas.48.1.41

Chanock, R. M., D. M. Rifkind, H. M. Kravetz, V. Knight, and K. M. Johnson. 1961. Respiratory disease in volunteers infected with Eaton agent: a preloiminary report. Proc. Natl. Acad. Sci. USA47:887-890.

Cherry, J. D. 1993. Anemia and mucocutaneous lesions due to Mycoplasma pneumoniae infections. Clin. Infect. Dis.17(Suppl. 1):S47-S51.

Cherry, J. D., and R. C. Welliver. 1976. Mycoplasma pneumoniae infections of adults and children. West. J. Med.125:47-55.

Chester, A., J. Kane, and V. Garagusi. 1975. Mycoplasma pneumonia with bilateral pleural effusions. Am. Rev. Respir. Dis.112:451-456.

Chryssanthopoulos, C., M. Eboriadou, K. Monti, V. Soubassi, and K. Sava. 2001. Fatal disseminated intravascular coagulation caused by Mycoplasma pneumoniae.Pediatr. Infect. Dis. J.20:634-635.

10.1067/mai.2000.109829

10.1016/S0264-410X(96)00068-0

10.1016/0264-410X(95)93318-4

10.1111/j.1348-0421.1992.tb02045.x

10.1093/clinids/21.5.1182

10.1128/iai.4.6.757-763.1971

Clyde W. A. Jr. 1979. Mycoplasma pneumonaie infections of man p. 275-306. In J. G. Tully and R. F. Whitcomb (ed.) The mycoplasmas II. Human and animal mycoplasmas vol. II. Academic Press New York N.Y.

Clyde, W. A., Jr. 1971. Mycoplasma pneumoniae pneumonia. Mil. Med.136:20-22.

Collier, A. M. 1983. Attachment by mycoplasmas and its role in disease. Rev. Infect. Dis.5(Suppl. 4):S685-S691.

Collier, A. M., and J. B. Baseman. 1973. Organ culture techniques with mcoplasmas. Ann. N. Y. Acad. Sci.225:277-289.

10.1016/S0732-8893(99)00070-X

Couch, R. B. 1964. Infection with artificially propagated Eaton agent (Mycoplasma pneumoniae): implications for development of attenuated vaccine for cold agglutinin-positive pneumonia. JAMA187:442-447.

10.1017/S0950268899003313

10.1006/mpat.2000.0395

10.1128/iai.58.12.4163-4165.1990

10.1046/j.1365-2958.2002.03207.x

10.1084/jem.167.2.718

Dandekar T. B. Snel S. Schmidt W. Lathe M. Suyama M. Huynen and P. Bork. 2002. Comparative genome analysis of the mollicutes p. 255-278. In S. Razin and R. Herrmann (ed.) Molecular biology and pathogenesis of mycoplasmas. Kluwer Academic/Plenum Publishers New York N.Y.

Davis, C. P., S. Cochran, J. Lisse, G. Buck, A. R. DiNuzzo, T. Weber, and J. A. Reinarz. 1988. Isolation of Mycoplasma pneumoniae from synovial fluid samples in a patient with pneumonia and polyarthritis. Arch. Intern. Med.148:969-970.

Daxboeck, F., G. Brunner, H. Popper, R. Krause, K. Schmid, G. J. Krejs, and C. Wenisch. 2002. A case of lung transplantation following Mycoplasma pneumoniae infection. Eur. J. Clin. Microbiol. Infect. Dis.21:318-322.

Daxboeck, F., K. Kircher, R. Krause, H. Heinzl, C. Wenisch, and G. Stanek. 2002. Effect of age on antibody titer to Mycoplasma pneumoniae. Scand. J. Infect. Dis.34:577-579.

10.1046/j.1469-0691.2003.00590.x

10.1093/clinids/17.Supplement_1.S83

Decanq, H. G., Jr., and F. A. Lee. 1965. Mycoplasma pneumoniae pneumonia. Massive pulmonary involvement and pleural effusion. JAMA194:1010-1011.

Decaux, G., M. Szyper, M. Ectors, A. Cornil, and L. Franken. 1980. Central nervous system complications of Mycoplasma pneumoniae. J. Neurol. Neurosurg. Psychiatr.43:883-887.

10.1128/jb.108.1.439-445.1971

Del Giudice, R. A., R. H. Purcell, T. R. Carski, and R. M. Chanock. Characterization of a new Mycoplasma species of human origin. Int. J. Syst. Bacteriol.24:147-153.

10.1099/00207713-35-3-285

10.1093/infdis/123.1.74

De Vos, M., L. Van Nimmen, and G. Baele. 1974. Disseminated intravascular coagulation during a fatal Mycoplasma pneumoniae infection. Acta Haematol.52:120-125.

10.3181/00379727-36-9380

10.1080/00365549950164067

Dominguez, A., S. Minguell, J. Torres, A. Serrano, J. Vidal, and L. Salleras. 1996. Community outbreak of acute respiratory infection by Mycoplasma pneumoniae. Eur. J. Epidemiol.12:131-134.

10.1128/JCM.38.3.965-970.2000

10.1128/JCM.39.3.1184-1186.2001

10.1086/318529

10.1099/00222615-48-12-1115

10.1128/JCM.37.1.14-17.1999

Dowdle, W. R., J. A. Stewart, J. T. Heyward, and R. Q. Robinson. 1967. Mycoplasma pneumoniae infections in a children's population: a five-year study. Am. J. Epidemiol.85:137-146.

10.1093/jac/dkg365

10.1078/1438-4221-00231

10.1084/jem.79.6.649

10.1007/BF01963842

10.1099/00221287-14-1-197

Edward, D. G. 1955. A suggested classification and nomenclature for organisms of the pleuropneumonia group. Int. Bull. Bacteriol. Nomencl.5:85-93.

10.1099/00221287-62-1-1

Edwards, E. A., Y. E. Crawford, W. E. Pierce, and R. O. Peckinpaugh. 1976. A longitudinal study of Mycoplasma pneumoniae: infections in Navy recruits by isolation and seroepidemiology. Am. J. Epidemiol.104:556-562.

Efthimiou, J., M. E. Hodson, P. Taylor, A. G. Taylor, and J. C. Batten. 1984. Importance of viruses and Legionella pneumophila in respiratory exacerbations of young adults with cystic fibrosis. Thorax39:150-154.

el-Khatib, M., and A. M. Lerner. 1975. Myocarditis in Mycoplasma pneumoniae pneumonia. Occurrence with hemolytic anemia and extraordinary titers of cold isohemagglutinins. JAMA231:493-494.

Ellison J. S. L. D. Olson and M. F. Barile. 1992. Immunity and vaccine development p. 491-504. In J. Maniloff R. N. McElhaney L. R. Finch and J. B. Baseman (ed.) Mycoplasmas: molecular biology and pathogenesis. American Society for Microbiology Washington D.C.

Emre, U., M. Bernius, P. M. Roblin, P. F. Gaerlan, J. T. Summersgill, P. Steiner, J. Schachter, and M. R. Hammerschlag. 1996. Chlamydia pneumoniae infection in patients with cystic fibrosis. Clin. Infect. Dis.22:819-823.

Esposito, S., R. Cavagna, S. Bosis, R. Droghetti, N. Faelli, and N. Principi. 2002. Emerging role of Mycoplasma pneumoniae in children with acute pharyngitis. Eur. J. Clin. Microbiol. Infect. Dis.21:607-610.

10.1002/ppul.10139

10.1378/chest.110.4.972

Farraj, R. S., R. B. McCully, J. K. Oh, and T. F. Smith. 1997. Mycoplasma-associated pericarditis. Mayo Clin. Proc.72:33-36.

Feder, H. M., Jr., T. Watkin, S. R. Cole, and R. Quintiliani. 1981. Severe meningoencephalitis: complicating Mycoplasma pneumoniae infection in a child. Arch. Pathol. Lab. Med.105:619-621.

10.1016/0732-8893(95)00175-1

Feikin, D. R., J. F. Moroney, D. F. Talkington, W. L. Thacker, J. E. Code, L. A. Schwartz, D. D. Erdman, J. C. Butler, and M. S. Cetron. 1999. An outbreak of acute respiratory disease caused by Mycoplasma pneumoniae and adenovirus at a federal service training academy: new implications from an old scenario. Clin. Infect. Dis.29:1545-1550.

Feizi, T., H. Maclean, R. G. Sommerville, and J. G. Selwyn. 1967. Studies on an epidemic of respiratory disease caused by Mycoplasma pneumoniae. Br. Med. J.1:457-460.

Feldman, C., R. Anderson, A. J. Theron, G. Ramafi, P. J. Cole, and R. Wilson. 1996. Roxithromycin, clarithromycin, and azithromycin attenuate the injurious effects of bioactive phospholipids on human respiratory epithelium in vitro. Inflammation21:655-665.

10.1128/iai.5.4.552-558.1972

10.1128/iai.1.6.559-565.1970

Fernald, G. W., and W. P. Glezen. 1973. Humoral and cellular immune responses to an inactivated Mycoplasma pneumoniae vaccine in children. J. Infect. Dis.127:498-504.

10.1007/s004310100775

File, T. M., Jr., B. Schlemmer, J. Garau, M. Cupo, and C. Young. 2001. Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin. J. Antimicrob. Chemother.48:67-74.

10.1128/AAC.41.9.1965

10.1128/AAC.46.6.1746-1754.2002

Fischman, R. A., K. E. Marschall, J. W. Kislak, and D. M. Greenbaum. 1978. Adult respiratory distress syndrome caused by Mycoplasma pneumoniae. Chest74:471-473.

Fisher, R. S., A. W. Clark, J. S. Wolinsky, I. M. Parhad, H. Moses, and M. R. Mardiney. 1983. Postinfectious leukoencephalitis complicating Mycoplasma pneumoniae infection. Arch. Neurol.40:109-113.

10.1093/clinids/17.Supplement_1.S37

Foy, H. M., M. K. Cooney, I. Allan, and G. E. Kenny. 1979. Rates of pneumonia during influenza epidemics in Seattle, 1964 to 1975. JAMA241:253-258.

10.1001/jama.1966.03110110083019

10.1093/infdis/139.6.681

Foy, H. M., G. E. Kenny, M. K. Cooney, I. D. Allan, and G. van Belle. 1983. Naturally acquired immunity to pneumonia due to Mycoplasma pneumoniae. J. Infect. Dis.147:967-973.

10.1001/jama.1970.03180090032006

Foy, H. M., C. M. Nolan, and I. D. Allan. 1983. Epidemiologic aspects of M. pneumoniae disease complications: a review. Yale J. Biol. Med.56:469-473.

Foy, H. M., C. G. Nugent, G. E. Kenny, R. McMahan, and J. T. Grayston. 1971. Repeated Mycoplasma pneumoniae pneumonia after 4 and one-half years. JAMA216:671-672.

10.1093/infdis/127.4.388

Fransen, H., M. Forsgren, Z. Heigl, and G. Tunevall. 1969. Studies on Mycoplasma pneumoniae in patients hospitalized with acute respiratory illness. Scand. J. Infect. Dis.1:91-98.

10.1128/iai.62.3.1008-1014.1994

Freundt, E. A., D. Taylor-Robinson, R. H. Purcell, R. M. Chanock, and F. T. Black. 1974. Proposal of Mycoplasma buccale nom. nov. and Mycoplasma faucium nom. nov. for Mycoplasma orale′types' 2 and 3, respectively. Int. J. Syst. Bacteriol.24:252-255.

10.1016/S1386-6532(99)00030-X

Gendrel, D. 1997. Antibiotic treatment of Mycoplasma pneumoniae infections. Pediatr. Pulmonol. Suppl.16:46-47.

Gerstenecker B. and E. Jacobs. 1993. Development of a capture-ELISA for the specific detection of Mycoplasma pneumonaie in patient's material p. 195-205. In I. Kahane and A. Adoni (ed.) Rapid diagnosis of mycoplasmas. Plenum Press New York N.Y.

Gil, J. C., R. L. Cedillo, B. G. Mayagoitia, and M. D. Paz. 1993. Isolation of Mycoplasma pneumoniae from asthmatic patients. Ann. Allergy70:23-25.

Gillberg, C. 1980. Schizophreniform psychosis in a case of Mycoplasma pneumoniae encephalitis. J. Autism Dev. Disord.10:153-158.

10.1007/BF02786466

10.1016/S0022-3476(71)80218-4

10.3109/00365549209052607

Gobel, U., G. H. Butler, and E. J. Stanbridge. 1984. Comparative analysis of mycoplasma ribosomal RNA operons. Isr. J. Med. Sci.20:762-764.

Golubjatnikov, R., V. D. Allen, M. P. Olmos-Blancarte, and S. L. Inhorn. 1975. Serologic profile of children in a Mexican highland community: prevalence of complement-fixing antibodies to Mycoplasma pneumoniae, respiratory syncytial virus and parainfluenza viruses. Am. J. Epidemiol.101:458-464.

10.1128/jcm.33.11.2823-2825.1995

Granstrom, M., T. Holme, A. M. Sjogren, A. Ortqvist, and M. Kalin. 1994. The role of IgA determination by ELISA in the early serodiagnosis of Mycoplasma pneumoniae infection, in relation to IgG and mu-capture IgM methods. J. Med. Microbiol.40:288-292.

10.3201/eid0503.990308

Gray, G. C., L. B. Duffy, R. J. Paver, S. D. Putnam, R. J. Reynolds, and G. H. Cassell. 1997. Mycoplasma pneumoniae: a frequent cause of pneumonia among U. S. Marines in southern California. Mil. Med.162:524-526.

Gray, G. C., D. C. McPhate, M. Leinonen, G. H. Cassell, E. P. Deperalta, S. D. Putnam, J. A. Karcher, M. H. Sawyer, A. Laurila, and J. D. Connor. 1998. Weekly oral azithromycin as prophylaxis for agents causing acute respiratory disease. Clin. Infect. Dis.26:103-110.

Gray, G. C., B. S. Mitchell, J. E. Tueller, E. R. Cross, and D. E. Amundson. 1994. Pneumonia hospitalizations in the US Navy and Marine Corps: rates and risk factors for 6,522 admissions, 1981-1991. Am. J. Epidemiol.139:793-802.

Grayston, J. T., G. E. Kenny, H. M. Foy, R. A. Kronmal, and E. R. Alexander. 1967. Epidemiological studies of Mycoplasma pneumoniae infections in civilians. Ann. N. Y. Acad. Sci.143:436-446.

Greenberg, H., C. M. Helms, H. Brunner, and R. M. Chanock. 1974. Asymptomatic infection of adult volunteers with a temperature sensitive mutant of Mycoplasma pneumoniae. Proc. Natl. Acad. Sci. USA71:4015-4019.

10.1128/JCM.37.1.1-7.1999

10.1128/JCM.41.1.514-515.2003

Gucuyener, K., F. Simsek, O. Yilmaz, and A. Serdaroglu. 2000. Methyl-prednisolone in neurologic complications of Mycoplasma pneumonia. Indian J. Pediatr.67:467-469.

Gump, D. W., C. A. Phillips, B. R. Forsyth, K. McIntosh, K. R. Lamborn, and W. H. Stouch. 1976. Role of infection in chronic bronchitis. Am. Rev. Respir. Dis.113:465-474.

10.1016/S0167-7012(00)00135-4

10.1128/IAI.70.2.649-654.2002

10.1128/IAI.69.6.3869-3876.2001

10.1097/00006454-199810000-00004

Hauksdottir, G. S., T. Jonsson, V. Sigurdardottir, and A. Love. 1998. Seroepidemiology of Mycoplasma pneumoniae infections in Iceland 1987-96. Scand. J. Infect. Dis.30:177-180.

10.1097/00006454-199811000-00004

Hernandez, L. A., G. E. Urquhart, and W. C. Dick. 1977. Mycoplasma pneumoniae infection and arthritis in man. Br. Med. J.2:14-16.

10.1590/S0100-879X2000000900005

10.1590/S0036-46652002000400005

Hill, A. C. 1991. Mycoplasma spermatophilum, a new species isolated from human spermatozoa and cervix. Int. J. Syst. Bacteriol.41:229-233.

10.1093/nar/24.22.4420

10.1128/jcm.29.9.2007-2012.1991

Hirschberg, L., and T. Holme. 1991. ELISA for detection of Mycoplasma pneumoniae antigens using monoclonal antibodies. APMIS99:475-481.

Hirschberg, L., T. Holme, and A. Krook. 1991. Human antibody response to the major adhesin of Mycoplasma pneumoniae: increase in titers against synthetic peptides in patients with pneumonia. APMIS99:515-520.

Hirschberg, L., A. Krook, C. A. Pettersson, and T. Vikerfors. 1988. Enzyme-linked immunosorbent assay for detection ofMycoplasma pneumoniae specific immunoglobulin M. Eur. J. Clin. Microbiol. Infect. Dis. 7:420-423.

Hirshberg, S. J., R. S. Charles, and J. B. Ettinger. 1996. Pediatric priapism associated with Mycoplasma pneumoniae. Urology47:745-746.

Hoek, K. L., G. H. Cassell, L. B. Duffy, and T. P. Atkinson. 2002. Mycoplasma pneumoniae-induced activation and cytokine production in rodent mast cells. J. Allergy Clin. Immunol.109:470-476.

10.1128/JCM.38.4.1382-1384.2000

Hsieh, C. C., R. B. Tang, C. H. Tsai, and W. Chen. 2001. Serum interleukin-6 and tumor necrosis factor-alpha concentrations in children with mycoplasma pneumonia. J. Microbiol. Immunol. Infect.34:109-112.

10.1084/jem.145.5.1328

10.1086/319258

10.1086/517753

10.1093/infdis/173.6.1445

10.1128/jb.172.1.504-506.1990

10.2169/internalmedicine.34.430

Jacobs E. 2002. Mycoplasma pneumoniae disease manifestations and epidemiology p. 519-530. In S. Razin and R. Herrman (ed.) Molecular biology and pathogenicity of mycoplasmas. Kluwer Academic/Plenum Publishers New York N.Y.

10.1093/clinids/17.1.79

Jacobs, E., M. Drews, A. Stuhlert, C. Buttner, P. J. Klein, M. Kist, and W. Bredt. 1988. Immunological reaction of guinea-pigs following intranasal Mycoplasma pneumoniae infection and immunization with the 168 kDa adherence protein. J. Gen. Microbiol.134:473-479.

10.1128/jcm.28.6.1194-1197.1990

10.1016/0882-4010(88)90098-8

10.1007/BF01586183

Jafri, H. S., and G. H. McCracken, Jr. 1999. Fluoroquinolones in paediatrics. Drugs58(Suppl. 2):43-48.

Jansson, E., A. Backman, K. Hakkarainen, A. Miettinen, and B. Seniusova. 1983. Mycoplasmas and arthritis. Z. Rheumatol.42:315-319.

Jensen, J. S., C. Heilmann, and N. H. Valerius. 1994. Mycoplasma pneumoniae infection in a child with AIDS. Clin. Infect. Dis.19:207.

10.1111/j.1699-0463.1989.tb00516.x

Jensen, K. J., L. B. Senterfit, W. E. Scully, T. J. Conway, R. F. West, and W. W. Drummy. 1967. Mycoplasma pneumoniae infections in children. An epidemiologic appraisal in families treated with oxytetracycline. Am. J. Epidemiol.86:419-432.

Johansson K.-E. and B. Pettersson. 2002. Taxonomy of mollicutes p. 1-29. In S. Razin and R. Herrman (ed.) Molecular biology and pathogenicity of mycoplasmas. Kluwer Academic/Plenum Publishers New York N.Y.

Joosting, A. C., R. M. Harwin, A. Coppin, P. Battaglia, and P. van der Hoef. 1976. A serological investigation of Mycoplasma pneumoniae infection on the Witwatersrand. S. Afr. Med. J.50:2134-2135.

10.1099/00222615-38-3-166

Kaku, M., S. Kohno, H. Koga, K. Ishida, and K. Hara. 1995. Efficacy of roxithromycin in the treatment of mycoplasma pneumonia. Chemotherapy41:149-152.

Kanayama, Y., K. Shiota, K. Kotumi, Y. Ikuno, R. Yasumoto, M. Ishii, and T. Inoue. 1982. Mycoplasma pneumoniae pneumonia associated with IgA nephropathy. Scand. J. Infect. Dis.14:231-233.

Karjalainen, J. 1990. A loud third heart sound and asymptomatic myocarditis during Mycoplasma pneumoniae infection. Eur. Heart J.11:960-963.

10.1136/jcp.46.12.1120

Kasahara, I., Y. Otsubo, T. Yanase, H. Oshima, H. Ichimaru, and M. Nakamura. 1985. Isolation and characterization of Mycoplasma pneumoniae from cerebrospinal fluid of a patient with pneumonia and meningoencephalitis. J. Infect. Dis.152:823-825.

Kashiwagi, S., J. Hayashi, H. Nomura, W. Kajiyama, H. Ikematsu, T. Shingu, K. Hayashida, and M. Kaji. 1985. An outbreak of Mycoplasma pneumoniae infections in a hospital in Japan. Kurume Med. J.32:293-296.

10.1136/thx.35.2.140

Keegan, B. M., N. J. Lowry, and J. Y. Yager. 1999. Mycoplasma pneumoniae: a cause of coma in the absence of meningoencephalitis. Pediatr. Neurol.21:822-825.

10.1128/AAC.45.9.2604-2608.2001

10.1128/jcm.28.9.2087-2093.1990

Kikuchi, M., Y. Tagawa, H. Iwamoto, H. Hoshino, and N. Yuki. 1997. Bickerstaff's brainstem encephalitis associated with IgG anti-GQ1b antibody subsequent to Mycoplasma pneumoniae infection: favorable response to immunoadsorption therapy. J. Child Neurol.12:403-405.

10.1542/peds.105.2.372

10.1086/513818

Kleemola, M., and C. Jokinen. 1992. Outbreak of Mycoplasma pneumoniae infection among hospital personnel studied by a nucleic acid hybridization test. J. Hosp. Infect.21:213-221.

Kleemola, M., and H. Kayhty. 1982. Increase in titers of antibodies to Mycoplasma pneumoniae in patients with purulent meningitis. J. Infect. Dis.146:284-288.

10.1007/BF02000413

10.1002/path.1700400108

10.1542/peds.107.3.e39

10.1017/S0950268800029551

Koletsky, R. J., and A. J. Weinstein. 1980. Fulminant Mycoplasma pneumoniae infection. Report of a fatal case, and a review of the literature. Am. Rev. Respir. Dis.122:491-496.

10.1128/JCM.38.11.4256-4259.2000

Koskiniemi, M. 1993. CNS manifestations associated with Mycoplasma pneumoniae infections: summary of cases at the University of Helsinki and review. Clin. Infect. Dis.17(Suppl. 1):S52-S57.

10.1164/ajrccm.158.3.9711092

10.1378/chest.121.6.1782

10.1016/S0966-842X(97)01168-2

10.1111/j.1365-2958.1996.tb02613.x

10.1128/iai.39.3.1180-1186.1983

10.1128/iai.39.2.830-836.1983

10.1128/iai.35.3.809-817.1982

Krause D. C. and D. Taylor-Robinson. 1992. Mycoplasmas which infect humans p. 417-444. In J. Maniloff R. N. McElhaney L. R. Finch and J. B. Baseman (ed.) Mycoplasmas: molecular biology and pathogenesis. American Society for Microbiology Washington D.C.

Krause, I., R. Wu, Y. Sherer, M. Patanik, J. M. Peter, and Y. Schoenfeld. 2002. In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations—a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases. Transfus. Med.12:133-139.

10.1016/S0021-9258(18)60527-7

Lambert, H. P. 1969. Infections caused by Mycoplasma pneumoniae. Br. J. Dis. Chest63:71-82.

Lambert, H. P. 1968. Mycoplasma pneumoniae infections. J. Clin. Pathol. Suppl.2:52-60.

10.1086/513631

Launes, J., A. Paetau, K. Linnavuori, and M. Iivanaineu. 1997. Direct invasion of the brain parenchyma by Mycoplasma pneumoniae. Acta Neurol. Scand.95:374.

10.1128/JCM.37.6.1721-1726.1999

Leibowitz, Z., P. Schvartzman, L. Epstein, I. Lis, and Y. Naot. 1988. An outbreak of Mycoplasma pneumoniae pneumonia in two kibbutzim: a clinical and epidemiologic study. Isr. J. Med. Sci.24:88-92.

10.1006/mcpr.1994.1017

Lepow, M. L., N. Balassanian, J. Emmerich, R. B. Roberts, M. S. Rosenthal, and E. Wolinsky. 1968. Interrelationships of viral, mycoplasmal, and bacterial agents in uncomplicated pneumonia. Am. Rev. Respir. Dis.97:533-545.

10.1016/S0025-7125(16)31749-7

10.1177/0009922891030004S12

Lewis, J. E., and C. Sheptin. 1972. Mycoplasmal pneumonia associated with abscess of the lung. Calif. Med.117:69-72.

10.1086/516124

10.1016/S0732-8893(01)00255-3

10.1016/S0732-8893(02)00421-2

Lieberman, D., S. Horowitz, O. Horovitz, F. Schlaeffer, and A. Porath. 1995. Microparticle agglutination versus antibody-capture enzyme immunoassay for diagnosis of community-acquired Mycoplasma pneumoniae pneumonia. Eur. J. Clin. Microbiol. Infect. Dis.14:577-584.

10.1007/BF02113582

Lin, W. C., P. I. Lee, C. Y. Lu, Y. C. Hsieh, H. P. Lai, C. Y. Lee, and L. M. Huang. 2002. Mycoplasma pneumoniae encephalitis in childhood. J. Microbiol. Immunol. Infect.35:173-178.

Lind, K. 1982. Serological cross-reactions between “Mycoplasma genitalium” and M. pneumoniae. Lancetii:1158-1159.

Lind, K., and M. W. Bentzon. 1976. Epidemics of Mycoplasma pneumoniae infection in Denmark from 1958 to 1974. Int. J. Epidemiol.5:267-277.

10.1023/A:1007353121693

Liu, C., M. D. Eaton, and J. T. Heyl. 1957. Studies on atypical pneumonia. II. Observations concerning the development and immunological characteristics of antibody in patients. J. Exp. Med.109:545.

Liu, C., P. Jayanetra, and D. W. Voth. 1970. Effect of combined Mycoplasma pneumoniae and pneumococcal infections in hamsters. Ann. N. Y. Acad. Sci.174:828-834.

10.1099/00207713-42-3-357

10.1016/S0022-3476(68)80305-1

10.1128/JCM.41.11.4915-4923.2003

Luby, J. P. 1991. Pneumonia caused by Mycoplasma pneumoniae infection. Clin. Chest Med.12:237-244.

10.1128/AAC.39.12.2770

10.1128/jcm.31.5.1088-1094.1993

Macfarlane, J. 1980. Mycoplasma pneumoniae infection, antibiotics and exanthema. Infection8:119-120.

Maisel, J. C., L. H. Babbitt, and T. J. John. 1967. Fatal Mycoplasma pneumoniae infection with isolation of organisms from lung. JAMA202:287-290.

Maniloff J. 1992. Phylogeny of mycoplasmas p. 549-559. In J. Maniloff R. N. McElhaney L. R. Finch and J. B. Baseman (ed.) Mycoplasmas: molecular biology and pathogenesis. American Society for Microbiology Washington D.C.

10.1097/00006454-200008000-00007

Markham, J. G. 1979. Mycoplasma pneumoniae infection in 1978. N. Z. Med. J.90:473-474.

10.1038/189247a0

Marrie, T. J. 1993. Mycoplasma pneumoniae pneumonia requiring hospitalization, with emphasis on infection in the elderly. Arch. Intern. Med.153:488-494.

10.1001/archinte.1997.00440360129015

10.1165/ajrcmb.24.5.4315

Martin, R. R., G. Warr, R. Couch, and V. Knight. 1973. Chemotaxis of human leukocytes: responsiveness to Mycoplasma pneumoniae. J. Lab. Clin. Med.81:520-529.

10.1080/00365549850160954

Meseguer, M. A., J. A. Perez-Molina, J. Fernandez-Bustamante, R. Gomez, I. Martos, and M. C. Quero. 1996. Mycoplasma pneumoniae pericarditis and cardiac tamponade in a ten-year-old girl. Pediatr. Infect. Dis. J.15:829-831.

Meyers, L. A., M. E. J. Newman, M. Martin, and S. Schrag. 2003. Applying network theory to epidemics: control measures for Mycoplasma pneumoniae outbreaks. Emerg. Infect. Dis.9:204-210.

Milla, E., L. Zografos, and B. Piguet. 1998. Bilateral optic papillitis following Mycoplasma pneumoniae pneumonia. Ophthalmologica212:344-346.

Miyata, M. 2002. Gliding motility of mycoplasma—a mechanism cannot be explained by today's biology. Nippon Saikingaku Zasshi57:581-595.

Mizutani, H. 1983. Immunologic responses in patients with Mycoplasma pneumoniae infections. Am. Rev. Respir. Dis.127:175-179.

Mogabgab, W. J. 1968. Mycoplasma pneumoniae and adenovirus respiratory illnesses in military and university personnel, 1959-1966. Am. Rev. Respir. Dis.97:345-358.

10.1164/ajrccm.160.1.9809041

Mok, J. Y., J. M. Inglis, and H. Simpson. 1979. Mycoplasma pneumoniae infection. A retrospective review of 103 hospitalised children. Acta Paediatr. Scand.68:833-839.

Mok, J. Y., P. R. Waugh, and H. Simpson. 1979. Mycoplasma pneuminia infection. A follow-up study of 50 children with respiratory illness. Arch. Dis. Child.54:506-511.

10.1093/oxfordjournals.aje.a112058

Monto, A. S., and S. K. Lim. 1971. The Tecumseh study of respiratory illness. 3. Incidence and periodicity of respiratory syncytial virus and Mycoplasma pneumoniae infections. Am. J. Epidemiol.94:290-301.

10.1128/iai.53.2.398-403.1986

Muldoon, R. L., J. Raucci, J. Kowalski, and K. Rajashekaraiah. 1982. An outbreak of Mycoplasma pneumoniae respiratory illness in a semi-closed religious commune. Ann. Emerg. Med.11:613-615.

10.1086/374559

10.1016/0002-9343(75)90574-4

10.1093/infdis/154.5.904

10.1128/jcm.24.5.892-893.1986

Naraqi, S., and S. A. Kabins. 1973. Mycoplasma pneumoniae monoarticular arthritis. J. Pediatr.83:621-623.

Narita, M. 2000. Detection of Mycoplasma pneumoniae DNA in cerebrospinal fluid and local immune response. Clin. Infect. Dis.30:405-406.

10.1093/clinids/23.3.522

Narita, M., Y. Matsuzono, T. Togashi, and N. Kajii. 1992. DNA diagnosis of central nervous system infection by Mycoplasma pneumoniae. Pediatrics90:250-253.

10.1128/CDLI.7.6.909-914.2000

10.1128/CDLI.8.5.1028-1030.2001

10.1016/S0022-3476(70)80485-1

10.1111/j.1348-0421.1974.tb00803.x

10.1016/0022-510X(96)00106-2

Noah, N. D. 1976. Epidemiology of Mycoplasma pneumoniae infection in the United Kingdom: an analysis of reports to the Public Health Laboratory Service of England and Wales. Infection4:25-28.

Noah, N. D. 1974. Mycoplasma pneumoniae infection in the United Kingdom—1967-73. Br. Med. J.2:544-546.

Nocard, E., and E. R. Roux. 1898. Le microbe de la peripneumonie. Ann. Inst. Pasteur (Paris)12:240-262.

10.1111/j.1348-0421.2001.tb01293.x

10.1136/thx.44.9.739

Opitz, O., K. Pietsch, S. Ehlers, and E. Jacobs. 1996. Cytokine gene expression in immune mice reinfected with Mycoplasma pneumoniae: the role of T cell subsets in aggravating the inflammatory response. Immunobiology196:575-587.

O'Riordan, J. I., B. Gomez-Anson, I. F. Moseley, and D. H. Miller. 1999. Long term MRI follow-up of patients with post infectious encephalomyelitis: evidence for a monophasic disease. J. Neurol. Sci.167:132-136.

10.1006/mcpr.1996.0043

Pasternack, A., H. Helin, T. Vanttinen, G. Jarventie, and T. Vesikari. 1979. Acute tubulointerstitial nephritis in a patient with Mycoplasma pneumoniae infection. Scand. J. Infect. Dis.11:85-87.

Patel, T., J. Pearl, J. Williams, D. Haverstock, D. Church, et al. 2000. Efficacy and safety of ten day moxifloxacin 400 mg once daily in the treatment of patients with community-acquired pneumonia. Respir. Med.94:97-105.

10.1111/j.1600-0404.1996.tb00200.x

10.1111/j.1651-2227.1981.tb05757.x

Pfausler, B., K. Engelhardt, A. Kampfl, H. Spiss, E. Taferner, and E. Schmutzhard. 2002. Post-infectious central and peripheral nervous system diseases complicating Mycoplasma pneumoniae infection. Report of three cases and review of the literature. Eur. J. Neurol.9:93-96.

10.1128/AAC.40.5.1175

10.1089/15362310260256909

10.3109/10408419709115140

Ponka, A. 1979. Arthritis associated with Mycoplasma pneumoniae infection. Scand. J. Rheumatol.8:27-32.

Ponka, A. 1979. Carditis associated with Mycoplasma pneumoniae infection. Acta Med. Scand.206:77-86.

Ponka, A. 1980. Central nervous system manifestations associated with serologically verified Mycoplasma pneumoniae infection. Scand. J. Infect. Dis.12:175-184.

Ponka, A. 1978. Clinical and laboratory manifestations in patients with serological evidence of Mycoplasma pneumoniae infection. Scand. J. Infect. Dis.10:271-275.

Ponka, A. 1979. The occurrence and clinical picture of serologically verified Mycoplasma pneumoniae infections with emphasis on central nervous system, cardiac and joint manifestations. Ann. Clin. Res.11(Suppl. 24):1-60.

Porath, A., F. Schlaeffer, and D. Lieberman. 1997. The epidemiology of community-acquired pneumonia among hospitalized adults. J. Infect.34:41-48.

10.1016/S0022-3476(05)80530-X

Pullman, J., J. Champlin, and P. S. Vrooman, Jr. 2003. Efficacy and tolerability of once-daily oral therapy with telithromycin compared with trovafloxacin for the treatment of community-acquired pneumonia in adults. Int. J. Clin. Pract.57:377-384.

Qasem, J. A., Z. U. Khan, G. Shiji, and A. S. Mustafa. 2002. Polymerase chain reaction as a sensitive and rapid method for specific detection of Mycoplasma pneumoniae in clinical samples. Microbiol. Res.157:77-82.

10.1086/317498

10.1016/0732-8893(95)00254-5

Rastawicki, W., and M. Jagielski. 1998. Electrophoretic and immunologic comparative analysis of Mycoplasma pneumoniae and Mycoplasma genitalium proteins. Med. Dosw. Mikrobiol.50:259-267.

Rautonen, J., M. Koskiniemi, and A. Vaheri. 1991. Prognostic factors in childhood acute encephalitis. Pediatr. Infect. Dis. J.10:441-446.

Rawadi, G., S. Roman-Roman, M. Castedo, V. Dutilleul, S. Susin, P. Marchetti, M. Geuskens, and G. Kroemer. 1996. Effects of Mycoplasma fermentans on the myelomonocytic lineage. Different molecular entities with cytokine-inducing and cytocidal potential. J. Immunol.156:670-678.

Razin S. 2002. Diagnosis of mycoplasmal infections p. 531-544. In S. Razin and R. Herrmann (ed.) Molecular biology and pathogenicity of mycoplasmas. Kluwer Academic/Plenum Publishers New York N.Y.

10.1006/mcpr.1994.1071

10.1128/MMBR.62.4.1094-1156.1998

10.1007/BF02112622

10.1016/S0021-9258(18)60528-9

10.1128/AAC.29.2.350

10.1128/AAC.28.1.141

10.1099/00207713-52-2-587

10.1016/0002-9343(86)90812-0

Rollins, S., T. Colby, and F. Clayton. 1986. Open lung biopsy in Mycoplasma pneumoniae pneumonia. Arch. Pathol. Lab. Med.110:34-41.

10.1016/0923-2494(91)90096-2

10.1152/physrev.00030.2002

Rottem S. 2002. Invasion of mycoplasmas into and fusion with host cells p. 391-402. In S. Razin and R. Herrmann (ed.) Molecular biology and pathogenicity of mycoplasmas. Kluwer Academic/Plenum Publishers New York N.Y.

10.1093/nar/28.1.60

10.1007/BF02098083

Sabato, A. R., D. M. Cooper, and Y. H. Thong. 1981. Transitory depression of immune function following Mycoplasma pneumoniae infection in children. Pediatr. Res.15:813-816.

10.1136/adc.59.11.1034

Said, M. H., M. P. Layani, S. Colon, G. Faraj, C. Glastre, and P. Cochat. 1999. Mycoplasma pneumoniae-associated nephritis in children. Pediatr. Nephrol.13:39-44.

Sakoulas, G. 2001. Brainstem and striatal encephalitis complicating Mycoplasma pneumoniae pneumonia: possible benefit of intravenous immunoglobulin. Pediatr. Infect. Dis. J.20:543-545.

Salzman, M. B., S. K. Sood, M. L. Slavin, and L. G. Rubin. 1992. Ocular manifestations of Mycoplasma pneumoniae infection. Clin. Infect. Dis.14:1137-1139.

Sande, M. A., F. Gadot, and R. P. Wenzel. 1975. Point source epidemic of Mycoplasma pneumoniae infection in a prosthodontics laboratory. Am. Rev. Respir. Dis.112:213-217.

Sands, M. J., Jr., and R. Rosenthal. 1982. Progressive heart failure and death associated with Mycoplasma pneumoniae pneumonia. Chest81:763-765.

10.1128/jcm.34.2.447-449.1996

Schonwald, S., M. Gunjaca, L. Kolacny-Babic, V. Car, and M. Gosev. 1990. Comparison of azithromycin and erythromycin in the treatment of atypical pneumonias. J. Antimicrob. Chemother.25(Suppl. A):123-126.

10.1007/BF02561528

Schonwald, S., V. Skerk, I. Petricevic, V. Car, L. Majerus-Misic, and M. Gunjaca. 1991. Comparison of three-day and five-day courses of azithromycin in the treatment of atypical pneumonia. Eur. J. Clin. Microbiol. Infect. Dis.10:877-880.

Schulman, P., T. C. Piemonte, and B. Singh. 1980. Acute renal failure, hemolytic anemia, and Mycoplasma pneumoniae. JAMA244:1823-1824.

10.1164/ajrccm.162.2.9903057

Schwarze, J. E., M. Makela, G. Cieslewicz, A. Dakham, M. Lahn, T. Ikemura, A. Joetham, and E. W. Gelfand. 1999. Transfer of the enhancing effect of respiratory syncytial virus infection on subsequent allergic airway sensitization by T lymphocytes. J. Immunol.163:5729-5734.

Scully, R. E., E. J. Mark, W. F. McNeely, and B. U. McNeely. 1992. Case records of the Massachusetts General Hospital, case 5—1992. N. Engl. J. Med.326:324-336.

Seggev, J. S., I. Lis, R. Siman-Tov, R. Gutman, H. Abu-Samara, G. Schey, and Y. Naot. 1986. Mycoplasma pneumoniae is a frequent cause of exacerbation of bronchial asthma in adults. Ann. Allergy57:263-265.

Sequeira, W., E. Jones, and D. M. Bronson. 1981. Mycoplasma pneumoniae infection with arthritis and a varicella-like eruption. JAMA246:1936-1937.

10.1128/JB.183.5.1621-1630.2001

Shepard, M. C. 1954. The recovery of pleuropneumonia-like organisms from Negro men with and without nongonococcal urethritis. Am. J. Syph. Gonor. Vener. Dis.38:113-124.

Shimizu, T., H. Mochizuki, M. Kato, M. Shigeta, A. Morikawa, and T. Hori. 1991. Immunoglobulin levels, number of eosinophils in the peripheral blood and bronchial hypersensitivity in children with Mycoplasma pneumoniae pneumonia. Arerugi40:21-27.

Shulman, S. T., J. G. Bartlett, W. A. J. Clyde, and E. M. Ayoub. 1972. The unusual severity of mycoplasmal pneumonia in children with sickle cell disease. N. Engl. J. Med.287:164-167.

Siegler, D. I. 1973. Lung abscess associated with Mycoplasma pneumoniae infection. Br. J. Dis. Chest67:123-127.

10.1099/00222615-33-4-253

Simonian, N., and D. Janner. 1998. Pleural effusion, hepatitis and hemolytic anemia in a twelve-year-old male child. Pediatr. Infect. Dis. J.17:173-174, 176-177.

10.1128/jcm.30.10.2638-2643.1992

10.1093/infdis/141.3.271

Smith, R., and L. Eviatar. 2000. Neurologic manifestations of Mycoplasma pneumoniae infections: diverse spectrum of diseases. A report of six cases and review of the literature. Clin. Pediatr.39:195-201.

10.1126/science.150.3693.226

10.1016/S0163-4453(88)94197-7

Stallman, N. D., B. C. Allan, and M. A. Wiemers. 1976. Infection with Mycoplasma pneumoniae: clinical and serological data on 286 patients. Med. J. Aust.1:340-343.

Steinberg, P., R. L. Horswood, H. Brunner, and R. M. Chanock. 1971. Temperature-sensitive mutants of Mycoplasma pneumoniae. II. Response of hamsters. J. Infect. Dis.124:179-187.

Steinberg, P., R. L. Horswood, and R. M. Chanock. 1969. Temperature-sensitive mutants of Mycoplasma pneumoniae. I. In vitro biologic properties. J. Infect. Dis.120:217-224.

Stephan, J. L., C. Galambrun, B. Pozzetto, F. Grattard, and P. Bordigoni. 1999. Aplastic anemia after Mycoplasma pneumoniae infection: a report of two cases. J. Pediatr. Hematol. Oncol.21:299-302.

Sterner, G., G. de Hevesy, G. Tunevall, and S. Wolontis. 1966. Acute respiratory illness with Mycoplasma pneumoniae. An outbreak in a home for children. Acta Paediatr. Scand.55:280-286.

Stevens, D., P. G. Swift, P. G. Johnston, P. J. Kearney, B. D. Corner, and D. Burman. 1978. Mycoplasma pneumoniae infections in children. Arch. Dis. Child.53:38-42.

Stopler, T., and D. Branski. 1986. Resistance ofMycoplasma pneumoniae to macrolides, lincomycin and streptogramin B. J. Antimicrob. Chemother. 18:359-364.

Stopler, T., C. B. Gerichter, and D. Branski. 1980. Antibiotic-resistant mutants of Mycoplasma pneumoniae. Isr. J. Med. Sci.16:169-173.

Stutman, H. R. 1987. Stevens-Johnson syndrome and Mycoplasma pneumoniae: evidence for cutaneous infection. J. Pediatr.111:845-847.

10.1128/iai.58.8.2669-2674.1990

10.1128/iai.61.3.816-822.1993

Suhs, R. H., and H. A. Feldman. 1966. Serologic epidemiologic studies with M. pneumoniae. II. Prevalence of antibodies in several populations. Am. J. Epidemiol.83:357-365.

10.1016/S0167-7012(01)00291-3

Szymanski, M., M. Petric, F. E. Saunders, and R. Tellier. 2002. Mycoplasma pneumoniae pericarditis demonstrated by polymerase chain reaction and electron microscopy. Clin. Infect. Dis.34:E16-E17.

Talkington D. F. Mycoplasma and Ureaplasma in central nervous system disorders. In M. Scheld R. Whitley and C. Marra (ed.) Infections of the central nervous system in press. Lippincott Williams & Wilkins Philadelphia Pa.

10.1128/JCM.36.4.1151-1153.1998

Talkington D. F. K. B. Waites S. B. Schwartz and R. E. Besser. 2001. Emerging from obscurity: understanding pulmonary and exrrapulmonary syndromes pathogenesis and epidemiology of human Mycoplasma pneumoniae infections p. 57-84. In W. M. Scheld W. A. Craig and J. M. Hughes (ed.) Emerging Infections 5. American Society for Microbiology Washington D.C.

Tanaka, G., Y. Nagatomo, Y. Kai, M. Matsuyama, M. Kuroki, T. Sasaki, K. Murai, A. Okayama, and H. Tsubouchi. 2002. Mycoplasma pneumonia of identical twin sisters with different clinical courses depending on the treatment. Kansenshogaku Zasshi76:1040-1044.

10.1183/09031936.96.09040669

10.1378/chest.121.5.1493

Taylor-Robinson D. 1996. Cidal activity testing p. 199-204. In J. G. Tully and S. Razin (ed.) Molecular and diagnostic procedures in mycoplasmology vol. II. Academic Press New York N.Y.

Taylor-Robinson, D. 1981. Mycoplasmal arthritis in man. Isr. J. Med. Sci.17:616-621.

Taylor-Robinson, D., J. Canchola, H. Fox, and R. M. Chanock. 1964. A newly identified oral mycoplasma (M. orale) and its relationship to other human mycoplasmas. Am. J. Hyg.80:135-148.

Taylor-Robinson, D., J. M. Gumpel, A. Hill, and A. J. Swannell. 1978. Isolation of Mycoplasma pneumoniae from the synovial fluid of a hypogrammaglobulinaemic patient in a survey of patients with inflammatory polyarthritis. Ann. Rheum. Dis.37:180-182.

10.1128/CDLI.7.5.778-780.2000

10.1128/jcm.33.5.1212-1214.1995

Thomas, N. H., J. E. Collins, S. A. Robb, and R. O. Robinson. 1993. Mycoplasma pneumoniae infection and neurological disease. Arch. Dis. Child.69:573-576.

10.1002/ppul.10191

Tjhie, J. H., P. H. Savelkoul, and C. M. Vandenbroucke-Grauls. 1997. Polymerase chain reaction evaluation for Mycoplasma pneumoniae. J. Infect. Dis.176:1124-1125.

10.3109/00365549709011844

10.1128/jcm.32.1.11-16.1994

10.1136/jcp.52.4.257

Tryon, V. V., and J. B. Baseman. 1987. The acquisition of human lactoferrin by Mycoplasma pneumoniae. Microb. Pathog.3:437-443.

Tryon V. V. and J. B. Baseman. 1992. Pathogenic determinants and mechanisms p. 457-471. In J. Maniloff (ed.) Mycoplasmas: molecular biology and pathogenesis. American Society for Microbiology Washington D.C.

Tully J. G. and S. Razin (ed.). 1996. Molecular and diagnostic procedures in mycoplasmology vol. 2. Diagnostic procedures. Academic Press New York N.Y.

10.1093/infdis/139.4.478

10.1099/00207713-33-2-387

Turtzo, D. F., and P. K. Ghatak. 1976. Acute hemolytic anemia with Mycoplasma pneumoniae pneumonia. JAMA236:1140-1141.

10.1128/jcm.30.5.1198-1204.1992

Ursi, D., J. P. Ursi, M. Ieven, M. Docx, P. Van Reempts, and S. R. Pattyn. 1995. Congenital pneumonia due to Mycoplasma pneumoniae. Arch. Dis. Child. Fetal Neonatal Ed.72:F118-F20.

10.1111/j.1699-0463.1992.tb03978.x

10.1007/BF01971997

10.1016/S0890-8508(95)90947-8

Vitullo, B. B., S. O'Regan, J. P. de Chadarevian, and B. S. Kaplan. 1978. Mycoplasma pneumonia associated with acute glomerulonephritis. Nephron21:284-288.

Von Bonsdorff, M., A. Ponka, and T. Tornroth. 1984. Mycoplasmal pneumonia associated with mesangiocapillary glomerulonephritis type II (dense deposit disease). Acta Med. Scand.216:427-429.

Wachowski, O., S. Demirakca, K.-M. Muller, and W. Scheurlen. 2003. Mycoplasma pneumoniae associated organising pneumonia in a 10 year old boy. Arch. Dis. Child.88:270-272.

Waites K. B. 2001. Mycoplasma p. 649-655. In D. Schlossberg (ed.) Current therapy of infectious disease. Mosby St. Louis Mo.

Waites K. B. C. M. Bebear J. A. Robertson D. F. Talkington and G. E. Kenny (ed.). 2001. Cumitech 34 Laboratory diagnosis of mycoplasmal infections. American Society for Microbiology Washington D.C.

10.1128/AAC.47.1.161-165.2003

10.1128/AAC.47.1.39-42.2003

10.1016/S0924-8579(03)00060-8

Waites K. B. Y. Rikihisa and D. Taylor-Robinson. 2003. Mycoplasma and ureaplasma p. 972-990. In P. R. Murray E. J. Baron J. H. Jorgensen M. A. Pfaller and R. H. Yolken (ed.) Manual of clinical microbiology 8th ed. American Society for Microbiology Washington D.C.

Waites K. B. D. F. Talkington and C. M. Bebear. 2002. Mycoplasmas p. 201-224. In A. L. Truant (ed.) Manual of commercial methods in clinical microbiology. American Society for Microbiology Washington D.C.

10.1016/S0732-8893(01)00250-4

Weinstein, M. P., and C. B. Hall. 1974. Mycoplasma pneumoniae infection associated with migratory polyarthritis. Am. J. Dis. Child.127:125-126.

Williamson, J., B. P. Marmion, T. Kok, R. Antic, and R. J. Harris. 1994. Confirmation of fatal Mycoplasma pneumoniae infection by polymerase chain reaction detection of the adhesin gene in fixed lung tissue. J. Infect. Dis.170:1052-1053.

10.1017/S0950268800050512

10.1128/jb.125.1.332-339.1976

10.1017/S0022172400061428

10.1097/00006454-199902000-00004

10.1016/S0882-4010(02)00190-0

10.1128/IAI.70.7.3649-3655.2002

Yayoshi, M., E. Hayatsu, and M. Yoshioka. 1989. Protective effects of Mycoplasma pneumoniae live vaccine or its hyperimmune serum on the experimental infection in mice. Kansenshogaku Zasshi63:684-691.

Yayoshi, M., T. Sasaki, and M. Yoshioka. 1992. Relationship between an 85 kDa protein and the protective effects of Mycoplasma pneumoniae. Microbiol. Immunol.36:455-464.

Yogev D. G. F. Browning and K. S. Wise. 2002. Genetic mechanisms of surface variation p. 417-444. In S. Razin and R. Herrmann (ed.) Molecular biology and pathogenicity of mycoplasmas. Kluwer Academic/Plenum Publishers New York N.Y.